Featured Research

from universities, journals, and other organizations

New Mexican Health-care Program Successful At Reducing Crippling Health Care Costs

Date:
April 7, 2009
Source:
Harvard University
Summary:
New research shows that Seguro Popular, a recently implemented Mexican health-care program, has reduced catastrophic health expenses by 60 percent among participating households.

Seguro Popular, a Mexican health care program instituted in 2003, has already reduced crippling health care costs among poorer households, according to an evaluation conducted by researchers at Harvard University in collaboration with researchers in Mexico.

The study was designed and led by Gary King, David Florence Professor of Government and director of the Institute for Quantitative Social Science at Harvard. The results are published in the current issue of The Lancet.

"The success of Seguro Popular in reducing catastrophic health expenditures is remarkable," says King, "not least because governmental money spent on the poor in many countries rarely reaches the intended recipients."

King's study of about 500,000 people is the largest-ever randomized health policy experiment. It features innovative research designs and statistical methods he and his colleagues developed that increase what we learn from an evaluation while simultaneously saving a great deal of money. The design includes several failsafe components that preserve the experimental randomization even if politics or other problems intervene, including those which have ruined most previous large scale public policy evaluations. The approach is now being implemented or considered for evaluations of many other public policy programs around the world.

Passed in 2003, Seguro Popular was developed to provide health care to 50 million Mexicans who otherwise lack coverage. Voluntary enrollment in the program, at no cost to the poor, provides access to health clinics, drugs, regular and preventative medical care, and the money to pay for it all. The program's primary goal is the reduction of catastrophic health expenses, those exceeding one-third of a household's yearly disposable income.

About a half a million people in 118,569 households were included in this study, which was conducted over 10 months. In the treatment clusters, 44 percent of households reported participating in the program, compared to 7.3 percent in control communities, which was approximately as expected. Among participating households, those suffering catastrophic health expenses were reduced by almost 60 percent, contributing to a 30 percent reduction in catastrophic health expenses across treatment communities.

The evaluation also highlighted areas in which the program was ineffective. Contrary to prior non-randomized studies, the researchers found no increase in utilization of health services, although longer-term research may show an increase. Health outcomes will also take longer to show an effect.

Before the program was instituted, 174 communities were paired up based on having similar background variables, such as the health of the community, size, and the number of schools. Then one community within each pair was randomly chosen to receive treatment: Families were encouraged to enroll in Seguro Popular, health facilities were built or upgraded, and medical personnel, drugs, and other supplies were provided. In the other community within each pair, no changes were made.

"One advantage of this design is that if one of the communities was to drop out of the study, due to interventions by politicians or for other reasons, the paired community would be removed as well, and the balance between the treated and control groups would not be affected. In contrast, classical randomized experiments are destroyed when even one community is lost. The matched pair design also decreased the margin of error to as little as one-sixth of what it would be with traditional experimental methods," says King. "That's the equivalent of collecting many more respondents, or randomizing throughout many more communities, for the same cost."

Seguro Popular in Mexico covers about the same number of people as are uninsured in America. King points out that there may be lessons for other countries to learn in the success of Seguro Popular.

King's co-authors were Emmanuela Gakidou of the University of Washington; Kosuke Imai of Princeton University; Jason Lakin, Clayton Nall, and Nirmala Ravishankar of Harvard; Ryan Moore of Washington University in St. Louis; Manett Vargas of the Ministry of Health in Mexico; Martha María Téllez-Rojo and Juan Eugenio Hernández Ávila of the National Institute of Public Health in Mexico; Mauricio Hernández Ávila of the Ministry of Health in Mexico and the National Institute of Public Health in Mexico; and Héctor Hernández Llamas of Conestadistica. Gakidou, Imai, Lakin, Nall, Ravishankar, Moore, and Vargas are all King's current or former students and affiliates at the Harvard Institute for Quantitative Social Sciences.

The research was funded by the Mexican Ministry of Health, the National Institute of Public Health in Mexico, and the Harvard Institute for Quantitative Social Science.


Story Source:

The above story is based on materials provided by Harvard University. Note: Materials may be edited for content and length.


Cite This Page:

Harvard University. "New Mexican Health-care Program Successful At Reducing Crippling Health Care Costs." ScienceDaily. ScienceDaily, 7 April 2009. <www.sciencedaily.com/releases/2009/04/090407194640.htm>.
Harvard University. (2009, April 7). New Mexican Health-care Program Successful At Reducing Crippling Health Care Costs. ScienceDaily. Retrieved August 21, 2014 from www.sciencedaily.com/releases/2009/04/090407194640.htm
Harvard University. "New Mexican Health-care Program Successful At Reducing Crippling Health Care Costs." ScienceDaily. www.sciencedaily.com/releases/2009/04/090407194640.htm (accessed August 21, 2014).

Share This




More Health & Medicine News

Thursday, August 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) — An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) — Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) — It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com
Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) — According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins